US Stock MarketDetailed Quotes
TMO Thermo Fisher Scientific
- 571.730
- -5.660-0.98%
Close Apr 25 16:00 ET
- 571.730
- 0.0000.00%
Post 18:54 ET
218.24BMarket Cap36.67P/E (TTM)
577.990High569.980Low1.18MVolume577.400Open577.390Pre Close678.19MTurnover0.31%Turnover Ratio37.01P/E (Static)381.71MShares603.42152wk High4.80P/B217.73BFloat Cap415.04352wk Low1.40Dividend TTM380.82MShs Float668.602Historical High0.24%Div YieldTTM1.39%Amplitude11.901Historical Low572.790Avg Price1Lot Size
Thermo Fisher Scientific Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | (Q1)Apr 1, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Oct 1, 2022 | (Q2)Jul 2, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -3.41%10.35B | -4.58%42.86B | -4.93%10.89B | -0.96%10.57B | -2.58%10.69B | -9.38%10.71B | 14.55%44.92B | 6.99%11.45B | 14.44%10.68B | 10.97B |
| Operating revenue | -3.41%10.35B | -4.58%42.86B | -4.93%10.89B | -0.96%10.57B | -2.58%10.69B | -9.38%10.71B | 14.55%44.92B | 6.99%11.45B | 14.44%10.68B | --10.97B |
| Cost of revenue | -8.07%6.04B | -0.72%25.76B | -5.13%6.49B | -1.84%6.26B | 1.02%6.44B | 3.40%6.57B | 32.55%25.94B | 25.62%6.84B | 36.25%6.38B | 6.37B |
| Gross profit | 3.99%4.31B | -9.86%17.1B | -4.62%4.39B | 0.33%4.32B | -7.57%4.25B | -24.23%4.14B | -3.40%18.97B | -12.33%4.61B | -7.50%4.3B | 4.6B |
| Operating expense | 6.00%2.61B | -6.52%9.78B | -8.59%2.46B | -7.46%2.37B | -3.26%2.49B | -6.66%2.47B | 11.17%10.46B | 0.75%2.69B | 8.66%2.56B | 2.57B |
| Selling and administrative expenses | -18.31%1.73B | -6.09%8.45B | -7.26%2.13B | -7.20%2.05B | -2.90%2.15B | -6.94%2.12B | 12.31%8.99B | 0.92%2.3B | 10.18%2.21B | --2.21B |
| Research and development costs | -4.34%331M | -9.11%1.34B | -16.37%327M | -9.12%319M | -5.48%345M | -4.95%346M | 4.62%1.47B | -0.26%391M | 0.00%351M | --365M |
| Depreciation amortization depletion | --551M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Depreciation and amortization | --551M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 1.01%1.69B | -13.98%7.32B | 0.94%1.93B | 11.76%1.95B | -13.04%1.76B | -40.67%1.68B | -16.80%8.51B | -25.85%1.92B | -24.09%1.74B | 2.03B |
| Net non-operating interest income expense | 45.45%-84M | -9.25%-496M | 31.93%-81M | -7.62%-113M | -32.14%-148M | -30.51%-154M | 7.91%-454M | 20.67%-119M | 11.76%-105M | -112M |
| Non-operating interest income | 91.10%279M | 223.16%879M | 106.00%309M | 261.76%246M | 394.44%178M | 711.11%146M | 532.56%272M | 1,263.64%150M | 655.56%68M | --36M |
| Non-operating interest expense | 21.00%363M | 89.39%1.38B | 44.98%390M | 107.51%359M | 120.27%326M | 120.59%300M | 35.45%726M | 67.08%269M | 35.16%173M | --148M |
| Other net income (expense) | 87.97%-19M | -140.37%-524M | -465.00%-113M | -89.19%-70M | -4,675.00%-183M | 4.24%-158M | 75.53%-218M | 96.50%-20M | -37M | 4M |
| Special income (charges) | 74.11%-29M | -302.63%-459M | -45.45%-80M | -154.55%-84M | -662.50%-183M | -5,500.00%-112M | 42.13%-114M | -19.57%-55M | -83.33%-33M | ---24M |
| -Less：Restructuring and merger&acquisition | -74.11%29M | 302.63%459M | 45.45%80M | 154.55%84M | 662.50%183M | 5,500.00%112M | -42.13%114M | 19.57%55M | 83.33%33M | --24M |
| Other non- operating income (expenses) | 121.74%10M | 37.50%-65M | -194.29%-33M | 450.00%14M | ---- | 71.78%-46M | 85.01%-104M | 106.65%35M | -122.22%-4M | --28M |
| Income before tax | 16.58%1.59B | -19.62%6.3B | -2.08%1.74B | 10.24%1.77B | -25.40%1.43B | -46.34%1.36B | -11.38%7.84B | -4.56%1.78B | -26.46%1.6B | 1.92B |
| Income tax | 510.87%281M | -59.60%284M | -23.12%133M | 70.97%53M | -73.74%52M | -84.72%46M | -36.61%703M | -14.78%173M | -88.56%31M | 198M |
| Earnings from equity interest net of tax | 192.00%23M | 65.70%-59M | 96.67%-1M | 76.39%-17M | 68.63%-16M | -31.58%-25M | -4,200.00%-172M | ---30M | -2,300.00%-72M | ---51M |
| Net income | 3.02%1.33B | -14.44%5.96B | 2.03%1.61B | 13.15%1.7B | -18.35%1.36B | -41.80%1.29B | -9.94%6.96B | -5.12%1.57B | -21.28%1.5B | 1.67B |
| Net income continuous Operations | 3.02%1.33B | -14.44%5.96B | 2.03%1.61B | 13.15%1.7B | -18.35%1.36B | -41.80%1.29B | -9.94%6.96B | -5.12%1.57B | -21.28%1.5B | --1.67B |
| Minority interest income | 33.33%4M | -500.00%-40M | -1,100.00%-24M | -766.67%-20M | -75.00%1M | -40.00%3M | 233.33%10M | -300.00%-2M | 200.00%3M | 4M |
| Net income attributable to the parent company | 3.03%1.33B | -13.74%6B | 3.43%1.63B | 14.72%1.72B | -18.21%1.36B | -41.81%1.29B | -10.03%6.95B | -4.95%1.58B | -21.40%1.5B | 1.66B |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 3.03%1.33B | -13.74%6B | 3.43%1.63B | 14.72%1.72B | -18.21%1.36B | -41.81%1.29B | -10.03%6.95B | -4.95%1.58B | -21.40%1.5B | 1.66B |
| Basic earnings per share | 3.89%3.47 | -12.56%15.52 | 4.71%4.22 | 16.23%4.44 | -16.94%3.53 | -40.99%3.34 | -9.53%17.75 | -4.05%4.03 | -20.91%3.82 | 4.25 |
| Diluted earnings per share | 4.22%3.46 | -12.37%15.45 | 4.74%4.2 | 16.62%4.42 | -16.82%3.51 | -40.82%3.32 | -9.40%17.63 | -3.84%4.01 | -20.88%3.79 | 4.22 |
| Dividend per share | 11.43%0.39 | 16.67%1.4 | 16.67%0.35 | 16.67%0.35 | 16.67%0.35 | 16.67%0.35 | 15.38%1.2 | 15.38%0.3 | 15.38%0.3 | 0.3 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg